Decrease in anaerobe-related bacteraemias and increase in Bacteroides species isolation rate from 1998 to 2007: A retrospective study

Anaerobe

Volumn 16, Issue 3, 2010, Pages 201-205

  Lazarovitch, Tsilia ^a   Freimann, Sarit ^a   Shapira, Galina ^a   Blank, Helena ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Anaerobic bacteraemia; Bacteroides species; Blood culture

Indexed keywords

ANAEROBIC BACTERIUM; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BACTEROIDES; BLOOD CULTURE; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ISRAEL; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; AGED; CLASSIFICATION; DIABETES MELLITUS, TYPE 2; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTOR;

AGED; BACTEREMIA; BACTEROIDES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; RISK FACTORS;

BACTEROIDES;

EID: 77953229044     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2009.09.003     Document Type: Article

References (25)

1. Goldstein E.J. Anaerobic bacteraemia. Clin Infect Dis 1996, 23(Suppl. 1):S97-101.
2. Fenner L., Widmer A.F., Straub C., Frei R. Is the incidence of anaerobic bacteraemia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol 2008, 46:2432-2434.
3. Brook I. Anaerobic infections in children. Microbes Infect 2002, 4:1271-1280.
4. Lassmann B., Gustafson D.R., Wood C.M., Rosenblatt J.E. Reemergence of anaerobic bacteraemia. Clin Infect Dis 2007, 44:895-900.
5. Blairon L., De Gheldre Y., Delaere B., Sonet A., Bosly A., Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 2006, 12:527-532.
6. Grohs P., Mainardi J.L., Podglajen I., Hanras X., Eckert C., Buu-Hoï A., et al. Relevance of routine use of the anaerobic blood culture bottle. J Clin Microbiol 2007, 45:2711-2715.
7. Muttaiyah S., Paviour S., Buckwell L., Roberts S.A. Anaerobic bacteraemia in patients admitted to Auckland city hospital: its clinical significance. N Z Med J 2007, 120:U2809.
8. Robert R., Deraignac A., Le Moal G., Ragot S., Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur J Clin Microbiol Infect Dis 2008, 27:671-678.
9. Iwata K., Takahashi M. Is anaerobic blood culture necessary? If so, who needs it?. 279 Am J Med Sci 2008, 336:58-63.
10. Ortiz E., Sande M.A. Routine use of anaerobic blood cultures: are they still indicated?. Am J Med 2000, 108:445-447.
11. Wilson J.R., Limaye A.P. Risk factors for mortality in patients with anaerobic bacteraemia. Eur J Clin Microbiol Infect Dis 2004, 23:310-316.
12. Thorpe T.C., Wilson M.L., Turner J.E., DiGuiseppi J.L., Willert M., Mirrett S., et al. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol 1990, 28:1608-1612.
13. McDonald L.C., Fune J., Gaido L.B., Weinstein M.P., Reimer L.G., Flynn T.M., et al. Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles. J Clin Microbiol 1996, 34:2180-2184.
14. Wilson M.L., Weinstein M.P., Mirrett S., Reimer L.G., Feldman R.J., Chuard C.R., et al. Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteraemia and fungemia. J Clin Microbiol 1995, 33:2265-2270.
15. Jousimies-Somer H.R., Summanen P., Citron D.M., Baron E.J., Wexler H.M., Finegold S.M. Wadsworth-KTL anaerobic bacteriology manual 2002, Star Publishing Company, Belmont, CA. 6th ed.
16. Lombardi D.P., Engleberg N.C. Anaerobic bacteraemia: incidence, patient characteristics, and clinical significance. Am J Med 1992, 92:53-60.
17. Dorsher C.W., Rosenblatt J.E., Wilson W.R., Ilstrup D.M. Anaerobic bacteraemia: decreasing rate over a 15-year period. Rev Infect Dis 1991, 13:633-636.
18. Salonen J.H., Eerola E., Meurman O. Clinical significance and outcome of anaerobic bacteraemia. Clin Infect Dis 1998, 26:1413-1417.
19. Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007, 20:593-621.
20. Pumbwe L., Skilbeck C.A., Wexler H.M. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three?. Anaerobe 2006, 12:211-220.
21. Nguyen M.H., Yu V.L., Morris A.J., McDermott L., Wagener M.W., Harrell L., et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteraemia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000, 30:870-876.
22. Aldridge K.E., Sanders C.V. Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin- sulbactam, cefoxitin, imipenem, and metronidazole. Anaerobe 2002, 8:301-305.
23. Gibson F.C., Onderdonk A.B., Kasper D.L., Tzianabos A.O. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol 1998, 160:5000-5006.
24. Bishara J., Wattad M., Leibovici L., Samra Z., Lev B., Abramson E., et al. Predictors for anaerobic bacteraemia beyond the source of infection: retrospective, nested, case-control study. Scand J Infect Dis 2009, 41:33-36.
25. Redondo M.C., Arbo M.D., Grindlinger J., Snydman D.R. Attributable mortality of bacteraemia associated with the Bacteroides fragilis group. Clin Infect Dis 1995, 20:1492-1496.